BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9097984)

  • 1. Effects of dietary bile acids on formation of azoxymethane-induced aberrant crypt foci in F344 rats.
    Seraj MJ; Umemoto A; Kajikawa A; Mimura S; Kinouchi T; Ohnishi Y; Monden Y
    Cancer Lett; 1997 May; 115(1):97-103. PubMed ID: 9097984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of ursodeoxycholic acid on azoxymethane-induced aberrant crypt foci formation in rat colon: in vitro potential role of intracellular Ca2+.
    Momen MA; Monden Y; Houchi H; Umemoto A
    J Med Invest; 2002 Feb; 49(1-2):67-73. PubMed ID: 11901763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of secondary bile acids, deoxycholic and lithocholic acids, on aberrant crypt foci growth in the postinitiation phases of colon carcinogenesis.
    Baijal PK; Fitzpatrick DW; Bird RP
    Nutr Cancer; 1998; 31(2):81-9. PubMed ID: 9770718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of bile acids on formation of azoxymethane-induced aberrant crypt foci in colostomized F344 rat colon.
    Lin CX; Umemoto A; Seraj MJ; Mimura S; Monden Y
    Cancer Lett; 2001 Aug; 169(2):121-6. PubMed ID: 11431100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of ursodeoxycholic acid on N-methylnitrosourea-induced colon carcinogenesis and colonic mucosal telomerase activity in F344 rats.
    Narisawa T; Fukaura Y; Terada K; Sekiguchi H
    J Exp Clin Cancer Res; 1999 Jun; 18(2):259-66. PubMed ID: 10464717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dietary deoxycholic acid and cholesterol on fecal steroid concentration and its impact on the colonic crypt cell proliferation in azoxymethane-treated rats.
    Hori T; Matsumoto K; Sakaitani Y; Sato M; Morotomi M
    Cancer Lett; 1998 Feb; 124(1):79-84. PubMed ID: 9500195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-enhancing effects of cholic acid are exerted on the early stages of colon carcinogenesis via induction of aberrant crypt foci with an enhanced growth phenotype.
    Baijal PK; Clow EP; Fitzpatrick DW; Bird RP
    Can J Physiol Pharmacol; 1998 Dec; 76(12):1095-102. PubMed ID: 10326831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of chenodeoxycholic acid on the development of aberrant crypt foci in the rat colon.
    Sutherland LA; Bird RP
    Cancer Lett; 1994 Jan; 76(2-3):101-7. PubMed ID: 7908606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of repeated boluses of sucrose on proliferation and on AOM-induced aberrant crypt foci in rat colon.
    Luceri C; Caderni G; Lancioni L; Aiolli S; Dolara P; Mastrandrea V; Scardazza F; Morozzi G
    Nutr Cancer; 1996; 25(2):187-96. PubMed ID: 8710688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary inulin suppresses azoxymethane-induced preneoplastic aberrant crypt foci in mature Fisher 344 rats.
    Verghese M; Rao DR; Chawan CB; Shackelford L
    J Nutr; 2002 Sep; 132(9):2804-8. PubMed ID: 12221249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ability of aberrant crypt foci characteristics to predict colonic tumor incidence in rats fed cholic acid.
    Magnuson BA; Carr I; Bird RP
    Cancer Res; 1993 Oct; 53(19):4499-504. PubMed ID: 8402621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of amount and types of dietary fat on intestinal bacterial 7 alpha-dehydroxylase and phosphatidylinositol-specific phospholipase C and colonic mucosal diacylglycerol kinase and PKC activities during stages of colon tumor promotion.
    Reddy BS; Simi B; Patel N; Aliaga C; Rao CV
    Cancer Res; 1996 May; 56(10):2314-20. PubMed ID: 8625306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon.
    Rao CV; Desai D; Simi B; Kulkarni N; Amin S; Reddy BS
    Cancer Res; 1993 Sep; 53(18):4182-8. PubMed ID: 8364913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modifying effect of tuna orbital oil rich in docosahexaenoic acid and vitamin D3 on azoxymethane-induced colonic aberrant crypt foci in rats.
    Kohno H; Yamaguchi N; Ohdoi C; Nakajima S; Odashima S; Tanaka T
    Oncol Rep; 2000; 7(5):1069-74. PubMed ID: 10948340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin.
    Wali RK; Khare S; Tretiakova M; Cohen G; Nguyen L; Hart J; Wang J; Wen M; Ramaswamy A; Joseph L; Sitrin M; Brasitus T; Bissonnette M
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1653-62. PubMed ID: 12496057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of aberrant crypt foci induced in rat colon with azoxymethane or methylnitrosourea by feeding cholic acid.
    Magnuson BA; Bird RP
    Cancer Lett; 1993 Jan; 68(1):15-23. PubMed ID: 8422645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modifying effects of naturally occurring products on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats.
    Kawamori T; Tanaka T; Hara A; Yamahara J; Mori H
    Cancer Res; 1995 Mar; 55(6):1277-82. PubMed ID: 7882322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursodeoxycholic acid inhibits the initiation and postinitiation phases of azoxymethane-induced colonic tumor development.
    Wali RK; Stoiber D; Nguyen L; Hart J; Sitrin MD; Brasitus T; Bissonnette M
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1316-21. PubMed ID: 12433708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further investigation of the effect of cholic acid on the induction, growth characteristics and stability of aberrant crypt foci in rat colon.
    Bird RP
    Cancer Lett; 1995 Jan; 88(2):201-9. PubMed ID: 7874694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids.
    Rao CV; Hirose Y; Indranie C; Reddy BS
    Cancer Res; 2001 Mar; 61(5):1927-33. PubMed ID: 11280748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.